29.77
Artivion Inc stock is traded at $29.77, with a volume of 396.01K.
It is up +3.62% in the last 24 hours and up +0.88% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$28.73
Open:
$28.92
24h Volume:
396.01K
Relative Volume:
0.90
Market Cap:
$1.38B
Revenue:
$384.90M
Net Income/Loss:
$-851.00K
P/E Ratio:
-1,488.50
EPS:
-0.02
Net Cash Flow:
$12.83M
1W Performance:
+1.81%
1M Performance:
+0.88%
6M Performance:
+3.01%
1Y Performance:
+28.49%
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AORT
Artivion Inc
|
29.77 | 1.38B | 384.90M | -851.00K | 12.83M | -0.02 |
![]()
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
Sep-27-22 | Reiterated | Lake Street | Buy |
Aug-08-22 | Initiated | Lake Street | Buy |
Mar-03-22 | Initiated | Stifel | Buy |
Artivion Inc Stock (AORT) Latest News
Artivion (NYSE:AORT) Now Covered by Canaccord Genuity Group - Defense World
Artivion (AORT) Receives 'Buy' Rating from Canaccord Genuity | A - GuruFocus
Canaccord Genuity initiates Artivion stock with buy rating on aortic repair bets - Investing.com Nigeria
Artivion (AORT) Initiated with Buy Rating by Canaccord Analyst | AORT Stock News - GuruFocus
Rhumbline Advisers Cuts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Sees Large Increase in Short Interest - Defense World
Kalkine: What Puts Artivion (NYSE:AORT) in Focus Across NYSE Composite Healthcare Movers? - Kalkine Media
Artivion to Participate in Upcoming Investor Conferences | AORT Stock News - GuruFocus
Artivion to Participate in Upcoming Investor Conferences - PR Newswire
Artivion Inc (AORT) Trading Down 3.65% on Jun 2 - GuruFocus
Artivion Sets Double Conference Appearance: Truist Securities and Citizens Medical Forum Coming Up - Stock Titan
Nuveen Asset Management LLC Trims Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Receives Average Rating of “Buy” from Analysts - Defense World
Artivion Completes Convertible Notes Exchange Agreement - TipRanks
Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Millennium Management LLC Has $4.73 Million Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Artivion Announces Closing of Transactions to Exchange $99.5 Mil - GuruFocus
Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock - PR Newswire
Director Anthony Semedo Sells 2,600 Shares of Artivion Inc (AORT) - GuruFocus
Artivion director Anthony B. Semedo sells $74,027 in shares - Investing.com Australia
Artivion director Anthony B. Semedo sells $74,027 in shares By Investing.com - Investing.com South Africa
Deutsche Bank AG Grows Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Ameriprise Financial Inc. Sells 3,851 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
D. E. Shaw & Co. Inc. Sells 4,507 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Bank of America Corp DE Sells 9,611 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Bought by BNP Paribas Financial Markets - Defense World
Artivion Executive Makes Significant Stock Sale! - TipRanks
Artivion SVP sells shares worth $287,854 By Investing.com - Investing.com Nigeria
Artivion SVP sells shares worth $287,854 - Investing.com Australia
The Manufacturers Life Insurance Company Sells 474 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion shareholders approve executive pay, additional equity By Investing.com - Investing.com South Africa
Artivion Shareholders Approve Directors and Compensation - TipRanks
Artivion shareholders approve executive pay, additional equity - Investing.com
Artivion, Inc. (NYSE:AORT) Stock Holdings Lifted by Northern Trust Corp - Defense World
Artivion to exchange notes for common stock in a private deal - Investing.com Australia
Artivion to exchange notes for common stock in a private deal By Investing.com - Investing.com South Africa
Artivion Slashes Debt: $95M Notes Converting to 4.1M Shares in Strategic Financial Move - Stock Titan
Have Artivion Insiders Been Selling Stock? - simplywall.st
Top Executive Sells Thousands of Artivion Shares! - TipRanks
Artivion raises 2025 revenue guidance to $423M-$435M with focus on AMDS and On-X opportunities - MSN
Tower Research Capital LLC TRC Sells 1,608 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Raymond James Financial Inc. Buys Shares of 9,628 Artivion, Inc. (NYSE:AORT) - Defense World
1 Healthcare Stock with Exciting Potential and 2 to Avoid - FinancialContent
Stifel maintains Artivion stock Buy rating, $30 target amid growth By Investing.com - Investing.com Nigeria
Artivion, Inc. (NYSE:AORT) Receives $31.40 Consensus PT from Brokerages - Defense World
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):